Description
ABT-737 is a novel and potent pan Bcl-2 inhibitor. ABT-737 has demonstrated efficacy in several forms of leukemia, lymphoma and small cell lung carcinoma.
Product Overview
Bcl-2 inhibitor
Stability
2 years -20 centigrade Powder
1 month -4 centigrade in DMSO
More than one month -80 centigrade in DMSO
Molecular Formula
C42H45ClN6O5S2
Chemical Name
4-[4-[(4'-chloro[1,1'-biphenyl]-2-yl)methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(dimethylamino)-1-[(phenylthio)methyl]propyl]amino]-3-nitrophenyl]sulfonyl]-Benzamide
Solubility
DMSO >24 mg/mL Water <1 mg/mL Ethanol <1 mg/mL